与GAD65-IgG相关的神经障碍的严重肌痛症的治疗策略:一个病例报告
Xiao-Na Xu1, Wen-Jun Luo2, Hui-Ning Li1
1Department of Neurology, Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin 300052, China.
Journal of neuroimmunology
|September 7, 2025
概括
本案例研究详细介绍了一名患有一般化骨髓灰质炎 (MG) 和胸腺瘤的患者,该患者患有GAD65抗体神经系统疾病. 在这个复杂的神经免疫病例中,早期的向免疫疗法显示出了有利的反应.
科学领域:
- 神经免疫学 神经免疫学
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
背景情况:
- 胸腺瘤可以引发显著的免疫失调,导致多种自身免疫性疾病.
- 一般化肌痛性肌痛症 (MG) 是一种影响神经肌肉结合的自身免疫性疾病.
- 谷氨酸脱碳酶65 (GAD65) 抗体相关的神经系统疾病代表了一个独特的自身免疫神经系统综合征.
研究的目的:
- 为了呈现一种罕见的同时发生的乙胆受体 (AChR) 抗体阳性MG,GAD65抗体相关的神经疾病和B2型胸腺瘤的罕见病例.
- 突出诊断和治疗的挑战,在管理复杂的神经免疫综合征.
- 强调多模式免疫疗法在治疗这种疾病中的重要性.
主要方法:
- 一个50岁妇女的临床病例介绍.
- 诊断工作,包括对ACHR和GAD65.5的抗体测试.
- 用efgartigimod,高剂量的皮质类固醇和rituximab进行治疗干预.
主要成果:
- 这位患者同时出现了AChR阳性MG和GAD65抗体相关的神经疾病.
- 一种B2型胸腺瘤被确定为免疫失调的可能触发因素.
- 多模式免疫疗法导致了良好的临床反应.
结论:
- 胸腺瘤相关的免疫失调可以表现为多种并发的自身免疫性疾病.
- 早期和有针对性的免疫调节对于管理复杂的神经免疫综合征至关重要.
- 这一案例为MG与GAD65-IgG相关的神经疾病的治疗提供了宝贵的见解,对于这些疾病没有标准化的治疗方法.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.8K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Myasthenia Gravis: Diagnostic Tests
1.9K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K
Disorders of the Skeletal Muscle
1.7K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
1.7K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.5K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.5K
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K

